Cargando…

Progress in the Development of Stem Cell-Derived Cell-Free Therapies for Skin Aging

INTRODUCTION: The skin is a vital organ as the body’s largest barrier, but its function declines with aging. Therefore, research into effective regeneration treatments must continue to advance. Stem cell transplantation, a cell-based therapy, has become a popular skin-aging treatment, although it co...

Descripción completa

Detalles Bibliográficos
Autores principales: Chou, Yoan, Alfarafisa, Nayla Majeda, Ikezawa, Maiko, Khairani, Astrid Feinisa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10676866/
https://www.ncbi.nlm.nih.gov/pubmed/38021432
http://dx.doi.org/10.2147/CCID.S434439
_version_ 1785149995339481088
author Chou, Yoan
Alfarafisa, Nayla Majeda
Ikezawa, Maiko
Khairani, Astrid Feinisa
author_facet Chou, Yoan
Alfarafisa, Nayla Majeda
Ikezawa, Maiko
Khairani, Astrid Feinisa
author_sort Chou, Yoan
collection PubMed
description INTRODUCTION: The skin is a vital organ as the body’s largest barrier, but its function declines with aging. Therefore, research into effective regeneration treatments must continue to advance. Stem cell transplantation, a cell-based therapy, has become a popular skin-aging treatment, although it comes with drawbacks like host immune reactions. Stem cell-derived cell-free therapies have emerged as an alternative, backed by promising preclinical findings. Stem cell secretomes and extracellular vesicles (EVs) are the key components in cell-free therapy from stem cells. However, comprehensive reviews on the mechanisms of such treatments for skin aging are still limited. PURPOSE: This review discusses stem cell-derived cell-free therapy’s potential mechanisms of action related to skin aging prevention by identifying specific molecular targets suitable for the interventions. METHODS: A search identified 27 relevant in vitro studies on stem cell-derived cell-free therapy interventions in skin aging model cells without restricting publication years using PubMed, Scopus, and Google Scholar. RESULTS: Stem cell-derived cell-free therapy can prevent skin aging through various mechanisms, such as (1) involvement of multiple regenerative pathways [NFkb, AP-1, MAPK, P-AKT, NRF2, SIRT-1]; (2) oxidative stress regulation [by reducing oxidants (HO-1, NQO1) and enhancing antioxidants (SOD1, CAT, GP, FRAP)]; (3) preventing ECM degradation [by increasing elastin, collagen, HA, TIMP, and reducing MMP]; (4) regulating cell activity [by reducing cell senescence (SA-β-gal), apoptosis, and cell cycle arrest (P53, P12, P16); and enhancing autophagy, cell migration, and cell proliferation (Ki67)] (5) Regulating the inflammatory pathway [by reducing IL-6, IL-1, TNF-⍺, and increasing TGF-β]. Several clinical trials have also revealed improvements in wrinkles, elasticity, hydration, pores, and pigmentation. CONCLUSION: Stem cell-derived cell-free therapy is a potential novel treatment for skin aging by cell rejuvenation through various molecular mechanisms.
format Online
Article
Text
id pubmed-10676866
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Dove
record_format MEDLINE/PubMed
spelling pubmed-106768662023-11-22 Progress in the Development of Stem Cell-Derived Cell-Free Therapies for Skin Aging Chou, Yoan Alfarafisa, Nayla Majeda Ikezawa, Maiko Khairani, Astrid Feinisa Clin Cosmet Investig Dermatol Review INTRODUCTION: The skin is a vital organ as the body’s largest barrier, but its function declines with aging. Therefore, research into effective regeneration treatments must continue to advance. Stem cell transplantation, a cell-based therapy, has become a popular skin-aging treatment, although it comes with drawbacks like host immune reactions. Stem cell-derived cell-free therapies have emerged as an alternative, backed by promising preclinical findings. Stem cell secretomes and extracellular vesicles (EVs) are the key components in cell-free therapy from stem cells. However, comprehensive reviews on the mechanisms of such treatments for skin aging are still limited. PURPOSE: This review discusses stem cell-derived cell-free therapy’s potential mechanisms of action related to skin aging prevention by identifying specific molecular targets suitable for the interventions. METHODS: A search identified 27 relevant in vitro studies on stem cell-derived cell-free therapy interventions in skin aging model cells without restricting publication years using PubMed, Scopus, and Google Scholar. RESULTS: Stem cell-derived cell-free therapy can prevent skin aging through various mechanisms, such as (1) involvement of multiple regenerative pathways [NFkb, AP-1, MAPK, P-AKT, NRF2, SIRT-1]; (2) oxidative stress regulation [by reducing oxidants (HO-1, NQO1) and enhancing antioxidants (SOD1, CAT, GP, FRAP)]; (3) preventing ECM degradation [by increasing elastin, collagen, HA, TIMP, and reducing MMP]; (4) regulating cell activity [by reducing cell senescence (SA-β-gal), apoptosis, and cell cycle arrest (P53, P12, P16); and enhancing autophagy, cell migration, and cell proliferation (Ki67)] (5) Regulating the inflammatory pathway [by reducing IL-6, IL-1, TNF-⍺, and increasing TGF-β]. Several clinical trials have also revealed improvements in wrinkles, elasticity, hydration, pores, and pigmentation. CONCLUSION: Stem cell-derived cell-free therapy is a potential novel treatment for skin aging by cell rejuvenation through various molecular mechanisms. Dove 2023-11-22 /pmc/articles/PMC10676866/ /pubmed/38021432 http://dx.doi.org/10.2147/CCID.S434439 Text en © 2023 Chou et al. https://creativecommons.org/licenses/by-nc/3.0/This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/ (https://creativecommons.org/licenses/by-nc/3.0/) ). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).
spellingShingle Review
Chou, Yoan
Alfarafisa, Nayla Majeda
Ikezawa, Maiko
Khairani, Astrid Feinisa
Progress in the Development of Stem Cell-Derived Cell-Free Therapies for Skin Aging
title Progress in the Development of Stem Cell-Derived Cell-Free Therapies for Skin Aging
title_full Progress in the Development of Stem Cell-Derived Cell-Free Therapies for Skin Aging
title_fullStr Progress in the Development of Stem Cell-Derived Cell-Free Therapies for Skin Aging
title_full_unstemmed Progress in the Development of Stem Cell-Derived Cell-Free Therapies for Skin Aging
title_short Progress in the Development of Stem Cell-Derived Cell-Free Therapies for Skin Aging
title_sort progress in the development of stem cell-derived cell-free therapies for skin aging
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10676866/
https://www.ncbi.nlm.nih.gov/pubmed/38021432
http://dx.doi.org/10.2147/CCID.S434439
work_keys_str_mv AT chouyoan progressinthedevelopmentofstemcellderivedcellfreetherapiesforskinaging
AT alfarafisanaylamajeda progressinthedevelopmentofstemcellderivedcellfreetherapiesforskinaging
AT ikezawamaiko progressinthedevelopmentofstemcellderivedcellfreetherapiesforskinaging
AT khairaniastridfeinisa progressinthedevelopmentofstemcellderivedcellfreetherapiesforskinaging